Effect and mechanism of dexamethasone on the function of  placental transport of glucose

Abstract

Abstract:

AIM: To explore the effect and mechanism of dexamethasone (DEX) on the function of placental transport of glucose. METHODS: One hundred and sixty premature pregnant women who received treatment and delivery in Hangzhou First People's Hospital were randomly divided into control group and DEX group (n=80). Ten placenta tissue samples were randomly selected from two groups, respectively. Immunohistochemistry was used to detect human placental lactogen. JEG-3 cell line used to research mechanism was divided into 4 groups according to different transfer vectors, i.e group pcDNA3.1, group pcDNA3.1-GRα, group Control siRNA and group GRα siRNA. The CCK-8 method was used to detect placental cell proliferation. TUNEL method was used to detect degree of apoptosis. Mitochondrial membrane potential (MMP) and glucose uptake were detected. Fluorescent probe was used to detect content of reactive oxygen species. Quantitative real-time polymerase chain reaction was used to detect the relative the expression level of GRα and GLUT.RESULTS:The strong expression of HPL in control group was more than that in DEX group. Compared with pcDNA3.1 group, cell proliferation, MMP level and glucose uptake increased significantly in pcDNA3.1-GRα group (P<0.05, P<0.01); yet cell apoptosis and reactive oxygen species (ROS) level decreased significantly (P<0.01) and the relative expression level of GRα, GLUT1 and GLUT3 increased significantly (P<0.01). Compared with control siRNA group, cell proliferation, MMP level and glucose uptake of GRα siRNA group decreased significantly (P<0.05, P<0.01); yet cell apoptosis and ROS level increased significantly (P<0.01) and the relative expression level of GRα, GLUT1 and GLUT3 decreased significantly (P<0.05). CONCLUSION: DEX can induce glucose transport function of placenta, which is likely related with ROS/AMPK pathway.

Key words: dexamethasone, glucose, glucocorticoid receptor, glucose transporter, reactive oxygen species

CLC Number:

R965.2

SHANG Hongkai, FU Aiping, CHEN Lufang, TONG Jinyi, SI Qi. Effect and mechanism of dexamethasone on the function of placental transport of glucose[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1221-1226.

References

［1］Ogawa R, Mori R, Sako M, et al. Drug treatment for bronchopulmonary dysplasia in Japan: questionnaire survey［J］. Pediatr Int, 2015, 57(1): 189-192.
［2］Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease［J］. Horm Behav, 2011, 59(3): 279-289.
［3］Braun T, Challis JR, Newnham JP, et al. Early life glucocorticoid exposure: the hypothalamic pituitary adrenal axis, placental function and long term disease risk［J］. Endocr Rev, 2013, 34(6): 885-916.
［4］Novakovic B, Gordon L, Robinson WP, et al. Glucose as a fetal nutrient: dynamic regulation of several glucose transporter genes by DNA methylation in the human placenta across gestation［J］. J Nutr Biochem, 2013, 24(1): 282-288.
［5］刘娜，张伟. 从“壮火”论糖皮质激素调节糖代谢作用机制［J］. 长春中医药大学学报, 2017, 33(1): 79-81.
［6］Braun T, Li S, Moss TJ, et al. Differential appearance of placentomes and expression of prostaglandin H synthase type 2 in placentome subtypes after betamethasone treatment of sheep late in gestation［J］. Placenta, 2011, 32(4): 295-303.
［7］Braun T, Husar A, Challis JR, et al. Growth restricting effects of a single course of antenatal betamethasone treatment and the role of human placental lactogen［J］. Placenta, 2013, 34(5): 407-415.
［8］Shang H, Meng W, Sloboda DM, et al. Effects of maternal dexamethasone treatment early in pregnancy on glucocorticoid receptors in the ovine placenta［J］. Reprod Sci, 2015, 22(5): 534-544.
［9］Brown K, Heller DS, Zamudio S, et al. Glucose transporter 3 (GLUT3) protein expression in human placenta across gestation［J］. Placenta, 2011, 32(12): 1041-1049.
［10］Khan H, Kusakabe KT, Wakitani S, et al. Quantitative expression and immunohistochemical detection of glucose transporters, GLUT1 and GLUT3 in the rabbit placenta during successful pregnancy［J］. J Vet Med Sci, 2011, 73(9): 1177-1183.
［11］ Inoki K, Ouyang H, Zhu T, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth［J］. Cell, 2006, 126(5): 955-968.
［12］Schultze SM, Hemmings BA, Niessen M, et al. PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis［J］. Expert Rev Mol Med, 2012, 14: e1.
［13］Kim SH, Hwang JT, Park HS, et al. Capsaicin stimulates glucose uptake in C2C12 muscle cells via the reactive oxygen species (ROS)/AMPK/p38 MAPK pathway［J］. Biochem Bioph Res Co, 2013, 439(1): 66-70.
［14］Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream［J］. Cell, 2007, 129(7): 1261-1274.
［15］Brett KE, Ferraro ZM, Holcik M, et al. Prenatal physical activity and diet composition affect the expression of nutrient transporters and mTOR signaling molecules in the human placenta［J］. Placenta, 2015, 36(2): 204-212.
［16］Aiko Y, Askew DJ, Aramaki S, et al. Differential levels of amino acid transporters System L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR［J］. BMC Pregnancy Childbirth, 2014, 14(1): 181-192.
［17］Ozmen A, Unek G, Kipmen-Korgun D, et al. Glucocorticoid exposure altered angiogenic factor expression via Akt/mTOR pathway in rat placenta［J］. Ann Anat, 2015, 198: 34-40.

[1]	HAO Xiao, ZHAO Mei, WANG Wenjing, ZHANG Feifei, LIU Huiliang, DANG Yi, LI Shuren, QI Xiaoyong. Application of sodium-glucose cotransporter 2 inhibitors in acute myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 824-831.
[2]	ZHAO Shifeng, SONG Xiangming, YAO Jianping. Tirzepatide: A new glucagon-like peptide-1 receptor/glucose-dependent insulinotropic peptide receptor dual agonist [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 220-227.
[3]	WANG Xin, LIU Weiying, WU Chen, KAI Jinjun, LIANG Xuejie, CHANG Yingxuan. Metformin regulates AMPK/SREBP-1 pathway and its clinical application [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1049-1054.
[4]	WANG Yali, HUO Xulei, CHEN Feng, LI Shenglan, ZHENG Xiaohong, WANG Can, LI Wenbin. Research progress on the antitumor effect of nifurtimox [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 955-960.
[5]	PENG Juan, FAN Linlin, LI Ranyi, LI Xiaoyu, LV Qianzhou, ZOU Yunzeng. Progress of pharmacotherapy for heart failure [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 373-381.
[6]	WEI Jifang, YUE Hongmei, LIU Nanyu, SONG Peipei, XIE Yingying, WANG Jiaqi, WEI Yaqian. Research progress on the relationship between thyroid hormone and idiopathic pulmonary fibrosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 307-313.
[7]	LI Wenxia, FANG Liuyuan, QIAN Shenxian. Mechanism of ferroptosis and its research progress in lymphoma [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 314-321.
[8]	ZHAN Zhuqin, BAI Haitao. Effects of different doses of dexamethasone on angiotensin II, its receptors and NO levels in septic kidney injury rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 995-1004.
[9]	LIU Xiaoping, LAI Xiangmao, OUYANG Zizhang, JIANG Sheng, ZHANG Ying. Nobiletin inhibits neonatal rat cardiomyocytes hypertrophy induced by high glucose [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 753-759.
[10]	YANG Hechun, SHI Daohua . Research progress of small molecule inhibitors that reverse tumor drug resistance by regulating tumor glucose metabolism [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 836-840.
[11]	LIU Xiaoling, SONG Zhenrong, FU Yuan, CHEN Min, SHI Ruizan, ZHANG Xuanping. Ursolic acid alleviates the injury of human aortic endothelial cells induced by high glucose and high fat#br# [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 522-531.
[12]	MA Yue, FAN Fangtian. Research progress of glucose 6 phosphorus dehydrogenase in malignant tumor [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1430-1436.
[13]	WU Wei, LI Guangpeng, ZHANG Jiangbo, KONG Lingyu, CAI Junyan, YANG Feiyun. Gastrodin combined with dexamethasone protects H9C2 cell from injury induced by oxygen-glucose deprivation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(11): 1244-1249.
[14]	ZHANG Cheng, FAN Manli, WANG Kun, QIN Zhiqiang, ZHOU Lanlan. Protective effect of dexamethasone implant on nephrotoxicity of adriamycin in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 610-617.
[15]	LI Guinv, REN Shaolin, SHEN Ruiming, JI Yongneng, CAI Cairong, SU Ruo. Metformin combined with glucocorticoid in the treatment of SLE patients with IGT [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 670-676.

Effect and mechanism of dexamethasone on the function of placental transport of glucose

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments